Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis

Karla Solo1,2, Shahar Lavi3, Conrad Kabali4

  • 1Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

BMJ (Clinical Research Ed.)
|October 12, 2019
PubMed

Insights

Adding ticagrelor or clopidogrel to aspirin significantly reduces saphenous vein graft failure after coronary artery bypass graft surgery. Tailor dual antiplatelet therapy based on patient outcomes and drug profiles.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Surgical Outcomes

Background:

  • Saphenous vein graft failure is a significant complication after coronary artery bypass graft (CABG) surgery.
  • Oral antithrombotic drugs are used to prevent graft failure, but optimal therapy remains debated.

Purpose of the Study:

  • To assess the comparative effectiveness of different oral antithrombotic drugs in preventing saphenous vein graft failure post-CABG.
  • To evaluate the safety profiles of these antithrombotic therapies regarding major bleeding, myocardial infarction, and death.

Main Methods:

  • A systematic review and network meta-analysis of randomized controlled trials.
  • Searched multiple databases (Medline, Embase, Web of Science, CINAHL, Cochrane Library) up to January 25, 2019.
  • Included trials investigating oral antiplatelets or anticoagulants for preventing saphenous vein graft failure in CABG patients.

Main Results:

  • 20 randomized controlled trials with 4803 participants were included.
  • Dual antiplatelet therapy with aspirin plus ticagrelor or aspirin plus clopidogrel showed moderate certainty evidence of reducing graft failure compared to aspirin monotherapy.
  • No significant differences in major bleeding, myocardial infarction, or death were observed among the antithrombotic therapies.

Conclusions:

  • Adding ticagrelor or clopidogrel to aspirin provides a significant absolute benefit in preventing saphenous vein graft failure post-CABG.
  • Personalized dual antiplatelet therapy selection is recommended, balancing efficacy and safety for individual patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
200
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
338
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
251
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
194
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
211
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
210